A large number of people are infected with HIV every year. Even today the only way to prevent AIDS (HIV AIDS) is precautions. Currently, there is no vaccine to prevent HIV. However, in the past few years, leading doctors around the world have developed drugs and vaccines that can significantly reduce the risk of HIV. WHO has raised awareness about one such new drug, LEN (Lenacapavir), which has been developed to protect people from the risk of HIV.
In fact, to prevent HIV, large amounts of medication are required daily. For some people, taking daily pills is difficult. In such situations, lenacapavir injection can prove to be effective and helpful. Because instead of taking pills daily, you only need to get this injection once every six months. This vaccine not only reduces the cost of expensive drugs but also helps fight new infections. It may also help save more lives. WHO recommends LENACAPAVIR, or LEN, as the best treatment to protect people at risk of HIV.
After years of research and clinical tests, LEN, an intramuscular injection called lenacapavir, has been found to be safe to prevent HIV infection. After receiving this vaccine, its presence in the body lasts for at least 56 weeks. It can prevent HIV. This vaccine has been found to be 100% effective in preventing HIV in women. This can prevent the spread of dangerous diseases like HIV.
According to experts, lenacapavir (Yeztugo) is a PrEP drug that prevents the HIV virus from entering the body. However, it is not a vaccine. This is because the lenacapavir vaccine prevents exposure to the HIV virus, but it cannot fight it once it has entered the body. American Bio Pharma has developed lenacapavir as a prophylactic drug. Lenacapavir is a capsid inhibitor, which weakens the capsid of the HIV virus and consequently stops the virus from spreading in the body.
People at risk of HIV infection can get this vaccine if they test negative for HIV. This vaccine may prove effective in preventing HIV. The person receiving the vaccine should weigh more than 35 kg. The person receiving the vaccine must not have any symptoms of HIV, and must also have a negative HIV test. The vaccine is given every six months, and a negative HIV test is required before each injection. Only after that the next dose is given. All three trials of this vaccine have been successful, and it has now been approved by the FDA.
New Delhi,New Delhi,Delhi
December 01, 2025 3:35 PM IST